CHMP is positive on two generic Taxoteres
This article was originally published in Scrip
The European Medicine Agency's scientific committee, the CHMP has this month issued positive opinions on four new generic medicines, including two versions of Sanofi's anticancer Taxotere (docetaxel).
You may also be interested in...
UK HTA body NICE is looking to the future and rethinking its approach to data and how they inform its guidance.
Performance-based managed entry agreements need to be made more effective, but this can only happen if countries relax their stance on confidentiality and share information on MEAs amongst themselves, says a working paper from the OECD.
The Netherlands will secure lower medicine prices by referencing Norway instead of Germany to set maximum prices.